BRAIN and NERVE－神経研究の進歩64巻2号

2012年02月発行

特集 生物学的精神医学の進歩

気分障害研究の最近の進歩

著者： 加藤忠史¹

所属機関： ¹理化学研究所脳科学総合研究センター精神疾患動態研究チーム

ページ範囲：P.119 - P.129

文献概要

はじめに

　近年，気分障害の研究は急速に進歩しており，全領域における最近の進歩をすべて総説することは不可能に近い。そこで本稿では，まず，2010年以降に主要雑誌にどのような気分障害の論文が出版されているかを概観したのち，これらの論文を中心に，必要に応じて関連論文を引用しながら，それらをこれまでの研究の流れの中に位置づけつつ，今後の方向性についても考えてみたい。

　まず，PubMedで2010年以降に主要雑誌に掲載された気分障害の論文を調べ，分類してみたところ（Fig.），生物学的研究ではゲノム研究が最も多く報告されており，これに次ぐのが脳画像，死後脳，動物モデルであった。

参考文献

1) Baum AE, Akula N, Cabanero M, Cardona I, Corona W, et al: A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13: 197-207, 2008

2) Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678, 2007

3) Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, et al: Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40: 1056-1058, 2008

4) McMahon FJ, Akula N, Schulze TG, Muglia P, Tozzi F, et al: Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1．Nat Genet 42: 128-131, 2010

5) Breen G, Lewis CM, Vassos E, Pergadia ML, Blackwood DH, et al: Replication of association of 3p21.1 with susceptibility to bipolar disorder but not major depression. Nat Genet 43: 3-5; author reply 5, 2011

6) Zeng Z, Wang T, Li T, Li Y, Chen P, et al: Common SNPs and haplotypes in DGKH are associated with bipolar disorder and schizophrenia in the Chinese Han population. Mol Psychiatry 16: 473-475, 2011

7) Takata A, Kawasaki H, Iwayama Y, Yamada K, Gotoh L, et al: Nominal association between a polymorphism in DGKH and bipolar disorder detected in a meta-analysis of East Asian case-control samples. Psychiatry Clin Neurosci 65: 280-285, 2011

8) Lee MT, Chen CH, Lee CS, Chen CC, Chong MY, et al: Genome-wide association study of bipolar I disorder in the Han Chinese population. Mol Psychiatry 16: 548-556, 2011

9) Takata A, Kim SH, Ozaki N, Iwata N, Kunugi H, et al: Association of ANK3 with bipolar disorder confirmed in East Asia. Am J Med Genet B Neuropsychiatr Genet 156B: 312-315, 2011

10) Muglia P, Tozzi F, Galwey NW, Francks C, Upmanyu R, et al: Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry 15: 589-601, 2010

11) Liu Y, Blackwood DH, Caesar S, de Geus EJ, Farmer A, et al: Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry 16: 2-4, 2011

12) Shi J, Potash JB, Knowles JA, Weissman MM, Coryell W, et al: Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry 16: 193-201, 2011

13) Bosker FJ, Hartman CA, Nolte IM, Prins BP, Terpstra P, et al: Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry 16: 516-532, 2011

14) Hattori E, Toyota T, Ishitsuka Y, Iwayama Y, Yamada K, et al: Preliminary genome-wide association study of bipolar disorder in the Japanese population. Am J Med Genet B Neuropsychiatr Genet 150B: 1110-1117, 2009

15) Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, et al: Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373: 234-239, 2009

16) Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, et al: Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752, 2009

17) Williams HJ, Norton N, Dwyer S, Moskvina V, Nikolov I, et al: Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry 16: 429-441, 2011

18) O'Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M, et al: Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 16: 286-292, 2011

19) Green EK, Grozeva D, Jones I, Jones L, Kirov G, et al: The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 15: 1016-1022, 2010

20) Craddock N, Jones L, Jones IR, Kirov G, Green EK, et al: Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype. Mol Psychiatry 15: 146-153, 2010

21) Breuer R, Hamshere ML, Strohmaier J, Mattheisen M, Degenhardt F, et al: Independent evidence for the selective influence of GABA(A) receptors on one component of the bipolar disorder phenotype. Mol Psychiatry 16: 587-589, 2011

22) Christoforou A, McGhee KA, Morris SW, Thomson PA, Anderson S, et al: Convergence of linkage, association and GWAS findings for a candidate region for bipolar disorder and schizophrenia on chromosome 4p. Mol Psychiatry 16: 240-242, 2011

23) Francks C, Tozzi F, Farmer A, Vincent JB, Rujescu D, et al: Population-based linkage analysis of schizophrenia and bipolar case-control cohorts identifies a potential susceptibility locus on 19q13．Mol Psychiatry 15: 319-325, 2010

24) Grozeva D, Kirov G, Ivanov D, Jones IR, Jones L, et al: Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry 67: 318-327, 2010

25) Cannon DM, Klaver JK, Gandhi SK, Solorio G, Peck SA, et al: Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder. Mol Psychiatry 16: 407-418, 2011

26) Erk S, Meyer-Lindenberg A, Schnell K, Opitz von Boberfeld C, Esslinger C, et al: Brain function in carriers of a genome-wide supported bipolar disorder variant. Arch Gen Psychiatry 67: 803-811, 2010

27) 加藤忠史（2009): 脳と精神疾患. 朝倉書店, 東京, 2009

28) Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, et al: Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 50: 651-658, 2001

29) Victor TA, Furey ML, Fromm SJ, Ohman A, Drevets WC: Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder. Arch Gen Psychiatry 67: 1128-1138, 2010

30) Liu YM, Tsai SY, Fleck DE, Strakowski SM: Cross-cultural comparisons on Wisconsin Card Sorting Test performance in euthymic patients with bipolar disorder. Psychiatry Res 189: 469-477, 2011

31) Erk S, Mikschl A, Stier S, Ciaramidaro A, Gapp V, et al: Acute and sustained effects of cognitive emotion regulation in major depression. J Neurosci 30: 15726-15734, 2010

32) Hamilton JP, Chen G, Thomason ME, Schwartz ME, Gotlib IH: Investigating neural primacy in Major Depressive Disorder: multivariate Granger causality analysis of resting-state fMRI time-series data. Mol Psychiatry 16: 763-772, 2011

33) Gotlib IH, Hamilton JP, Cooney RE, Singh MK, Henry ML, et al: Neural processing of reward and loss in girls at risk for major depression. Arch Gen Psychiatry 67: 380-387, 2010

34) Greicius MD, Krasnow B, Reiss AL, Menon V: Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A 100: 253-258, 2003

35) Sheline YI, Barch DM, Price JL, Rundle MM, Vaishnavi SN, et al: The default mode network and self-referential processes in depression. Proc Natl Acad Sci U S A 106: 1942-1947, 2009

36) van Tol MJ, van der Wee NJ, van den Heuvel OA, Nielen MM, Demenescu LR, et al: Regional brain volume in depression and anxiety disorders. Arch Gen Psychiatry 67: 1002-1011, 2010

37) Chen MC, Hamilton JP, Gotlib IH: Decreased hippocampal volume in healthy girls at risk of depression. Arch Gen Psychiatry 67: 270-276, 2010

38) Baaré WF, Vinberg M, Knudsen GM, Paulson OB, Langkilde AR, et al: Hippocampal volume changes in healthy subjects at risk of unipolar depression. J Psychiatr Res 44: 655-662, 2010

39) Sanacora G, Treccani G, Popoli M: Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62: 63-77, 2012

40) Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, et al: A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63: 856-864, 2006

41) Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, et al: A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67: 793-802, 2010

42) Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, et al: mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329: 959-964, 2010

43) Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, et al: NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475: 91-95, 2011

44) Robinson TE, Kolb B: Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47: 33-46, 2004

45) Duman RS, Malberg J, Thome J: Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 46: 1181-1191, 1999

46) Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, et al: Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809, 2003

47) Vollmayr B, Simonis C, Weber S, Gass P, Henn F: Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biol Psychiatry 54: 1035-1040, 2003

48) Holick KA, Lee DC, Hen R, Dulawa SC: Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 33: 406-417, 2008

49) Reif A, Fritzen S, Finger M, Strobel A, Lauer M, et al: Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry 11: 514-522, 2006

50) Kitamura T, Saitoh Y, Takashima N, Murayama A, Niibori Y, et al: Adult neurogenesis modulates the hippocampus-dependent period of associative fear memory. Cell 139: 814-827, 2009

51) Clelland CD, Choi M, Romberg C, Clemenson GD Jr, Fragniere A, et al: A functional role for adult hippocampal neurogenesis in spatial pattern separation. Science 325: 210-213, 2009

52) Sahay A, Scobie KN, Hill AS, O'Carroll CM, Kheirbek MA, et al: Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature 472: 466-470, 2011

53) Snyder JS, Soumier A, Brewer M, Pickel J, Cameron HA: Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 476: 458-461, 2011

54) McClung CA: Circadian rhythms and mood regulation: Insights from pre-clinical models. Eur Neuropsychopharmacol Suppl4: S683-S693, 2011

55) Dzirasa K, McGarity DL, Bhattacharya A, Kumar S, Takahashi JS, et al: Impaired limbic gamma oscillatory synchrony during anxiety-related behavior in a genetic mouse model of bipolar mania. J Neurosci 31: 6449-6456, 2011

56) Kozikowski AP, Gunosewoyo H, Guo S, Gaisina IN, Walter RL, et al: Identification of a glycogen synthase kinase-3β inhibitor that attenuates hyperactivity in CLOCK mutant mice. ChemMedChem 6: 1593-1602, 2011

57) Coque L, Mukherjee S, Cao JL, Spencer S, Marvin M, et al: Specific role of VTA dopamine neuronal firing rates and morphology in the reversal of anxiety-related, but not depression-related behavior in the ClockΔ19 mouse model of mania. Neuropsychopharmacology 36: 1478-1488, 2011

58) Kubota M, Kasahara T, Iwamoto K, Komori A, Ishiwata M, et al: Therapeutic implications of down-regulation of cyclophilin D in bipolar disorder. Int J Neuropsychopharmacol 13: 1355-1368, 2010

59) Bernard R, Kerman IA, Thompson RC, Jones EG, Bunney WE, et al: Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry 16: 634-646, 2011

60) Soetanto A, Wilson RS, Talbot K, Un A, Schneider JA, et al: Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans. Arch Gen Psychiatry 67: 448-457, 2010

61) Kaneko N, Kudo K, Mabuchi T, Takemoto K, Fujimaki K, et al: Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus. Neuropsychopharmacology 31: 2619-2626, 2006

62) Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, et al: A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 11: 198-209, 2008

63) Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, Reddy R, Aschner M, et al: Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 16: 751-762, 2011

64) Rao JS, Harry GJ, Rapoport SI, Kim HW: Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 15: 384-392, 2010

65) Benes FM, Lim B, Matzilevich D, Walsh JP, Subburaju S, et al: Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc Natl Acad Sci U S A 104: 10164-10169, 2007

66) Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, et al: Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61: 300-308, 2004

67) Konradi C, Zimmerman EI, Yang CK, Lohmann KM, Gresch P, et al: Hippocampal interneurons in bipolar disorder. Arch Gen Psychiatry 68: 340-350, 2011

68) Kato T, Kato N: Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2: 180-190, 2000

69) Andreazza AC, Shao L, Wang JF, Young LT: Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 67: 360-368, 2011

70) Berk M, Copolov DL, Dean O, Lu K, Jeavons S, et al: N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial. Biol Psychiatry 64: 468-475, 2008

71) Cataldo AM, McPhie DL, Lange NT, Punzell S, Elmiligy S, et al: Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathol 177: 575-585, 2010

72) Duric V, Banasr M, Licznerski P, Schmidt HD, Stockmeier CA, et al: A negative regulator of MAP kinase causes depressive behavior. Nat Med 16: 1328-1332, 2010

73) Thakker-Varia S, Jean YY, Parikh P, Sizer CF, Jernstedt Ayer J, et al: The neuropeptide VGF is reduced in human bipolar postmortem brain and contributes to some of the behavioral and molecular effects of lithium. J Neurosci 30: 9368-9380, 2010

74) Gass P, Hellweg R: Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker for affective disorders? Int J Neuropsychopharmacol 13: 1-4, 2010

75) Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Prickaerts J, et al: Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety. World J Biol Psychiatry 2011 Sep 5 ［Epub ahead of print］

76) Fuchikami M, Morinobu S, Segawa M, Okamoto Y, Yamawaki S, et al: DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression PLoS One 6: e23881, 2011

77) Sugawara H, Iwamoto K, Bundo M, Ueda J, Miyauchi T, et al: Hypermethylation of serotonin transporter gene in bipolar disorder detected by epigenome analysis of discordant monozygotic twins. Translational Psychiatry 1: e24, 2011

78) Kato T, Hayashi-Takagi A, Toyota T, Yoshikawa T, Iwamoto K: Gene expression analysis in lymphoblastoid cells as a potential biomarker of bipolar disorder. J Hum Genet 56: 779-783, 2011

79) Müller N, Myint AM, Schwarz MJ: Inflammatory biomarkers and depression. Neurotox Res 19: 308-318, 2011

80) Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, et al: Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol 12: 447-458, 2009

81) Sheline YI, Pieper CF, Barch DM, Welsh-Bohmer K, McKinstry RC, et al: Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry 67: 277-285, 2010

82) Newson RS, Hek K, Luijendijk HJ, Hofman A, Witteman JC, et al: Atherosclerosis and incident depression in late life. Arch Gen Psychiatry 67: 1144-1151, 2010

83) Bromberger JT, Schott LL, Kravitz HM, Sowers M, Avis NE, et al: Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry 67: 598-607, 2010

84) Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, et al: Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 363: 123-135, 2010

85) Ströhle A: Physical activity, exercise, depression and anxiety disorders. J Neural Transm 116: 777-784, 2009

86) Wolff E, Ströhle A: Causal associations of physical activity/exercise and symptoms of depression and anxiety. Arch Gen Psychiatry 67: 540-541, 2010

87) De Moor MH, Boomsma DI, Stubbe JH, Willemsen G, de Geus EJ: Testing causality in the association between regular exercise and symptoms of anxiety and depression. Arch Gen Psychiatry 65: 897-905, 2008

88) George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, et al: Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry 67: 507-516, 2010

89) Lieverse R, Van Someren EJ, Nielen MM, Uitdehaag BM, Smit JH, et al: Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial. Arch Gen Psychiatry 68: 61-70, 2011